S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease

National Pharmaceutical Congress (NPC) Podcast

1

0:00

-31:32

S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease

Jul 17, 2025

Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.

Discussion about this episode

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

NPC Healthbiz Weekly

S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease

Discussion about this episode